Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

AC Immune Sa

TRADE

NASDAQ: ACIUHealthcare / Biotechnology / Switzerland
9.41+0.21+2.28%Vol 9 0201Y Perf 3.07%
Jun 22nd, 2018 16:00
BID9.41 ASK9.46
Open9.33 Previous Close9.20
Pre-Market- After-Trading-
 - -%  - -%
Target Price
22.00 
Analyst Rating
Strong Buy 1.00
Potencial %
133.79 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★★+     48.46
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★+     47.36
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)540 
Earnings Rating
Neutral
Price Range Ratio 52wk %
42.89 
Earnings Date
8th Aug 2018

Today's Price Range

9.339.50

 

52wk Range

6.0313.91

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-9.52%
3 Months
-17.17%
6 Months
-26.20%
1 Year
3.07%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ACIU9.410.21002.28
AAPL184.92-0.5400-0.29
GOOG1 155.48-2.1800-0.19
MSFT100.41-0.7300-0.72
XOM81.381.69002.12
WFC53.94-0.4300-0.79
JNJ122.841.39001.14
FB201.740.24000.12
GE13.050.29002.27
JPM105.75-1.7600-1.64
...

TickerPriceChg.%52 Week High
KMX80.1912.8681.67
MRO21.487.8322.12
APC74.116.6974.72
PCG42.925.9071.57
PDCO24.625.7648.29
NFX30.755.2035.20
DVN43.285.1845.16
FTI32.345.1435.00
HES64.574.6365.89
PXD185.654.29213.40
XEC97.694.18130.16
COP67.784.1071.71
SWN5.473.806.72
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 13.30
Current Ratio 13.60
Long Term Debt to Total Capital 0.00
Total Debt to Equity 0.00
Interest Coverage -179.80
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-144.20
EBITDA Margin-140.70
Pre-tax Profit Margin-
Profit Margin-88.93
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 5.13
PS Ratios 27.19
Price to Cash Flow 35.80
Price to Free Cash Flow -20.40
Cash Flow Per Share -0.42
Price to Tangible Book4.97
Book Value per Share1.87
Enterprise Value (in ths.)441 058
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -22.66
Return on Assets (5Y Avg) -
ROA last 12 Months -20.47
Return on Capital (5Y Avg) -
ROC last 12 Months -24.06
Return on invested Capital Q -10.42
Return on invested Capital Y-20.46
Assets Turnover0.10
Receivables Turnover6.80
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)20 267
Revenue per Share 0.35
Revenue Growth 3 Years -16.11
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-0.23-0.2013.04
Q04 2017-0.06-
Q03 2017-0.20-0.1620.00
Q02 2017-0.07-0.22-214.29
Q01 2017-0.17-0.170.00
----
----
----
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.2373.86Positive
9/2018 QR-0.2877.60Positive
12/2018 FY-1.05--
12/2019 FY-1.09--
Next Report Date8th Aug 2018
Estimated EPS Next Report-0.23
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume9 020
Shares Outstanding (in ths.)57 390
Trades Count24
Dollar Volume56 478
Avg. Volume47 425
Avg. Weekly Volume26 610
Avg. Monthly Volume25 572
Avg. Quarterly Volume31 226

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

51%49%

Bearish Bullish

63%37%

Bearish Bullish

69%31%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x